Looks like most everyone has left this board. Hat
Post# of 30013
![](/assets/46931549/no_avatar_available_thumb.jpg)
I think the sale of DX division could help turn this thing around. Also, MANF for RP, from what I have been able to read, would be a nice asset for a big pharma. Either would infuse some cash and help us move forward with additional MANF indications and/or ESS. Hoping GC has another surprise up his sleeve and he drops it on us soon.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)